A 68-year-old man with COPD is prescribed multiple medications including an inhaled anticholinergic agent. Which of the following is NOT a recognized adverse effect or contraindication of anticholinergic drugs?

Explanation

## Adverse Effects and Contraindications of Anticholinergic Drugs ### Recognized Adverse Effects (Options 0, 1, 3) **Option 0 — Urinary retention:** - Anticholinergics inhibit parasympathetic innervation of the detrusor muscle - Causes urinary hesitancy and retention - Major risk in elderly men with BPH - This is a REAL and SERIOUS adverse effect **Option 1 — Mydriasis and cycloplegia:** - Anticholinergics block parasympathetic control of ciliary muscle and iris sphincter - Cause mydriasis (pupil dilation) and cycloplegia (loss of accommodation) - Can precipitate acute angle-closure glaucoma in narrow-angle glaucoma patients - This is a REAL and SERIOUS adverse effect **Option 3 — Tachycardia:** - Anticholinergics remove parasympathetic (vagal) inhibition of the heart - Cause tachycardia and increased cardiac workload - Contraindicated in coronary artery disease, arrhythmias, and heart failure - This is a REAL and SERIOUS adverse effect ### NOT a Recognized Adverse Effect (Option 2) — **CORRECT ANSWER** **Key Point:** Anticholinergic drugs DECREASE salivation and bronchial secretions — they do NOT increase them. **High-Yield:** Anticholinergic effects on secretions: - **Dry mouth** (xerostomia) — common and bothersome - **Decreased bronchial secretions** — actually beneficial in COPD and asthma (reduces mucus plugging) - **Decreased sweating** — can impair thermoregulation Option 2 states the OPPOSITE of what actually occurs. Anticholinergics are used in respiratory disease precisely because they reduce secretions and improve airway clearance. ### Mnemonic: Anticholinergic Adverse Effects **"SLUDGE" (Cholinergic excess) vs. Anticholinergic effects (OPPOSITE):** - **S**alivation → Dry mouth (decreased) - **L**acrimation → Dry eyes (decreased) - **U**rination → Urinary retention (INCREASED risk) - **D**efecation → Constipation (INCREASED risk) - **G**I motility → Decreased GI motility, ileus - **E**yes → Mydriasis, cycloplegia (INCREASED risk of angle-closure glaucoma) ### Contraindications and Cautions Table | Condition | Reason for Caution/Contraindication | | --- | --- | | **Narrow-angle glaucoma** | Mydriasis precipitates acute angle-closure | | **BPH / urinary retention** | Worsens urinary obstruction | | **Coronary artery disease** | Tachycardia increases myocardial O₂ demand | | **Cardiac arrhythmias** | Tachycardia and increased automaticity | | **Heart failure** | Increased HR worsens cardiac output | | **Pyloric stenosis / bowel obstruction** | Decreased GI motility worsens obstruction | | **Myasthenia gravis** | Worsens muscle weakness | **Clinical Pearl:** In COPD patients, anticholinergic inhalers (ipratropium, tiotropium) are BENEFICIAL because they reduce mucus production and improve airway clearance. The decreased secretions are a therapeutic advantage, not a side effect.